Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 30,763 articles published since 2009
|||| 45 

These are the 30763 published articles about Pancreatic Neoplasms that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
301 Editorial Neoadjuvant therapy for localized pancreatic cancer: support is growing? 2015

Evans, Douglas B / Ritch, Paul S / Erickson, Beth A. ·From the Pancreatic Cancer Program, Departments of Surgery, Medicine, and Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI. ·Ann Surg · Pubmed #25599323.

ABSTRACT: -- No abstract --

302 Editorial p21-activated kinase 4: a druggable target in the elusive oncogenic KRAS pathway? 2015

Azmi, Asfar S / Mohammad, Ramzi M. ·Department of Oncology, Wayne State University School of Medicine, 4100 John R, HWCRC 732, Detroit, MI 48201, USA. ·Future Med Chem · Pubmed #25582328.

ABSTRACT: -- No abstract --

303 Editorial Additional support for neoadjuvant therapy in the management of pancreatic cancer. 2015

Christians, Kathleen K / Evans, Douglas B. ·Pancreatic Cancer Program and the Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA, kchristi@mcw.edu. ·Ann Surg Oncol · Pubmed #25519932.

ABSTRACT: -- No abstract --

304 Editorial FOLFIRINOX: desert, oasis, or mirage? 2015

Ferrone, Cristina R. ·Massachusetts General Hospital, Surgery, Boston, MA, USA, cFERRONE@mgh.harvard.edu. ·Ann Surg Oncol · Pubmed #25490873.

ABSTRACT: -- No abstract --

305 Editorial Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact. 2015

Roesli, Christoph. ·Junior Research Group Biomarker Discovery, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. ·Expert Rev Proteomics · Pubmed #25407217.

ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a median overall survival of 6 months. Late diagnosis due to the absence of specific symptoms during disease development, in addition to extensive metastatic potential and resistance to chemotherapy and radiotherapy, are the most important reasons for short survival. Research efforts have therefore been focused on the development of early disease detection. However, the only US FDA-approved clinical biomarker, CA19-9, is considered inapplicable for screening and/or early detection of PDAC. The following editorial provides the reader with a short introduction to the topic of PDAC and gives focus to the current state of proteomic research in the field of PDAC biomarker discovery. This editorial also highlights the efforts made to subdivide this tumor entity and the potential clinical impact of patient stratification. Finally, the author provides opinions on the impact of proteomics to PDAC subtype stratification over the next 5 years.

306 Editorial [Chemo-sensitivity study in pancreatic cancer]. 2014

Lee, Kwang Hyuck. · ·Korean J Gastroenterol · Pubmed #25675541.

ABSTRACT: -- No abstract --

307 Editorial Introduction. 2014

Hruban, Ralph H / Klimstra, David S. · ·Semin Diagn Pathol · Pubmed #25441312.

ABSTRACT: -- No abstract --

308 Editorial MAX-ing out MYC: a novel small molecule inhibitor against MYC-dependent tumors. 2014

Chio, Iok In Christine / Yordanov, Georgi / Tuveson, David. ·Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (IICC, GY, DT) · Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (GY). ·J Natl Cancer Inst · Pubmed #25430851.

ABSTRACT: -- No abstract --

309 Editorial Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies? 2014

Zheng, Lei. ·Departments of Oncology & Surgery, The Sidney Kimmel Cancer Center, & the Skip Viragh Center for Pancreatic Cancer Research & Clinical Care, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 488, Baltimore, MD 21231, USA. ·Immunotherapy · Pubmed #25428641.

ABSTRACT: -- No abstract --

310 Editorial [The diagnosis and treatment for pancreatic cancer: current status and future directions]. 2014

Zhao, Yupei. ·Email: zhao8028@263.net. ·Zhonghua Wai Ke Za Zhi · Pubmed #25410774.

ABSTRACT: -- No abstract --

311 Editorial Targeting IL-17 for pancreatic cancer prevention. 2014

McAllister, Florencia / Leach, Steven D. ·Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX. · The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY. ·Oncotarget · Pubmed #25393980.

ABSTRACT: -- No abstract --

312 Editorial Intraductal papillary mucinous neoplasms of the pancreas. 2014

Tanaka, Masao. ·From the Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ·Pancreas · Pubmed #25333396.

ABSTRACT: -- No abstract --

313 Editorial Snapshots April-August 2014. 2014

Anonymous2430808. · ·Pancreatology · Pubmed #25278301.

ABSTRACT: -- No abstract --

314 Editorial [Coffee and the pancreas: a half life of medical truth]. 2014

Frossard, Jean-Louis / Moradpour, Darius. · ·Rev Med Suisse · Pubmed #25276994.

ABSTRACT: -- No abstract --

315 Editorial Insights into the role of nicotine in pancreatic stem cell activation and acinar dedifferentiation. 2014

Ponnusamy, Moorthy P / Batra, Surinder K. ·Department of Biochemistry and Molecular Biology, Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska. · Department of Biochemistry and Molecular Biology, Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: sbatra@unmc.edu. ·Gastroenterology · Pubmed #25265575.

ABSTRACT: -- No abstract --

316 Editorial Volume-outcome in cancer surgery: why has the data not affected policy change? 2014

Evans, Douglas B / Tsai, Susan. ·Pancreatic Cancer Program, Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA, devans@mcw.edu. ·Ann Surg Oncol · Pubmed #25239003.

ABSTRACT: -- No abstract --

317 Editorial Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. 2014

Li, Chenggang / Zhao, Zhiming / Liu, Rong. ·Department of Surgical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, People's Republic of China, lcgang301@sohu.com. ·Tumour Biol · Pubmed #25172098.

ABSTRACT: -- No abstract --

318 Editorial The increasing diversity of KRAS signaling in pancreatic cancer. 2014

Siveke, Jens T. ·II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address: jens.siveke@lrz.tum.de. ·Gastroenterology · Pubmed #25167989.

ABSTRACT: -- No abstract --

319 Editorial Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected]. 2014

Toriola, Adetunji T / Fields, Ryan C. ·Department of Surgery, Division of Public Health Sciences, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA. ·Future Oncol · Pubmed #25145419.

ABSTRACT: -- No abstract --

320 Editorial Mistletoe treatment for cancer--promising or passé? 2014

Lordick, Florian. ·University Cancer Center Leipzig (UCCL), University of Leipzig. ·Dtsch Arztebl Int · Pubmed #25142074.

ABSTRACT: -- No abstract --

321 Editorial More harm than good? 2014

Gnerlich, Jennifer L / Posner, Mitchell C. ·Department of Surgery, University of Chicago, Chicago, Illinois, USA. ·Ann Surg Oncol · Pubmed #25023543.

ABSTRACT: -- No abstract --

322 Editorial The role of radiotherapy in the management of upper gastrointestinal and hepato-biliary and pancreatic cancers: current status and future directions. 2014

Mukherjee, S / Symonds, R P. ·MRC/CRUK Oxford Institute for Radiation Oncology and Churchill Hospital, Oxford, UK. Electronic address: Somnath.mukherjee@oncology.ox.ac.uk. · Department of Cancer Studies & Molecular Medicine, University of Leicester, Leicester Royal Infirmary, Leicester, UK. ·Clin Oncol (R Coll Radiol) · Pubmed #24996376.

ABSTRACT: -- No abstract --

323 Editorial Cellular and molecular conspirators in pancreas cancer. 2014

Hingorani, Sunil R. ·Clinical Research Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA and Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA 98195, USA srh@fhcrc.org. ·Carcinogenesis · Pubmed #24987024.

ABSTRACT: -- No abstract --

324 Editorial [Editorial]. 2014

Ghadimi, Michael. · ·Zentralbl Chir · Pubmed #24967997.

ABSTRACT: -- No abstract --

325 Editorial Liver and pancreatic cancer related to hepatitis B exposure: has the jury reached a verdict? 2014

Jakab, S Simona. ·Department of Medicine, Section of Digestive Diseases, Yale New Haven Hospital Transplant Center, Yale University, New Haven, CT. ·J Clin Gastroenterol · Pubmed #24921214.

ABSTRACT: -- No abstract --

Back · Next